MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer
Jialin Shang(State Key Laboratory of Oncogene and Related Genes), Jian Zhang(Jinan Central Hospital)
Cited by 65
Related Papers
Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells
|Cell Death and Disease|2015|94
IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats
|Stem Cell Research & Therapy|2022|68
SIRT3-SOD2-ROS pathway is involved in Linalool-induced glioma cell apoptotic death
|Acta Biochimica Polonica|2017|64
Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D<sub>3</sub> in colorectal cancer
|Theranostics|2020|49
Inhibition of SENP1 induces radiosensitization in lung cancer cells
|Experimental and Therapeutic Medicine|2013|38